Multiparametric MRI for prostate cancer localization in correlation to whole‐mount histopathology

Purpose:

To prospectively evaluate multiparametric magnetic resonance imaging (MRI) for accurate localization of intraprostatic tumor nodules, with whole‐mount histopathology as the gold standard.

Materials and Methods:

Seventy‐five patients with biopsy‐proven, intermediate, and high‐risk prostate cancer underwent preoperative T2‐weighted (T2w), dynamic contrast‐enhanced (DCE) and diffusion‐weighted (DW) MRI at 1.5T. Localization of suspicious lesions was recorded for each of 24 standardized regions of interest on the different MR images and correlated with the pathologic findings. Generalized estimating equations (GEE) were used to estimate the sensitivity, specificity, accuracy, positive, and negative predictive value for every MRI modality, as well as to evaluate the influence of Gleason score and pT‐stage. Tumor volume measurements on histopathological specimens were correlated with those on the different MR modalities (Pearson correlation).

Results:

DW MRI had the highest sensitivity for tumor localization (31.1% vs. 27.4% vs. 44.5% for T2w, DCE, and DW MRI, respectively; P < 0.005), with more aggressive or more advanced tumors being more easily detected with this imaging modality. Significantly higher sensitivity values were obtained for the combination of T2w, DCE, and DW MRI (58.8%) as compared to each modality alone or any combination of two modalities (P < 0.0001). Tumor volume can most accurately be assessed by means of DW MRI (r = 0.75; P < 0.0001).

Conclusion:

Combining T2w, DCE, and DW imaging significantly improves prostate cancer localization. J. Magn. Reson. Imaging 2013;37:1392–1401. © 2012 Wiley Periodicals, Inc.     

Gadoxetic acid‐enhanced MRI versus multiphase multidetector row computed tomography for evaluating the viable tumor of hepatocellular carcinomas treated with image‐guided tumor therapy

Purpose:

To compare the diagnostic performance of gadoxetic acid‐enhanced MRI with that of multi‐phase 40‐ or 64‐multidetector row computed tomography (MDCT) to evaluate viable tumors of hepatocellular carcinomas (HCCs) treated with image‐guided tumor therapy.

Materials and Methods:

A total of 108 patients with 162 HCCs (56 lesions with viable tumor and 106 without viable tumor) treated by means of transcatheter arterial chemoembolization or radiofrequency ablation were retrospectively included in this study. All patients underwent multi‐phase CT at 40‐ or 64‐MDCT and gadoxetic acid‐enhanced MRI using 3.0 Tesla (T). Two observers independently and randomly reviewed the CT and MR images of the treated lesions. The diagnostic performance of two techniques for the evaluation of the viable tumors in the treated lesions was assessed with a receiver operating characteristic (ROC) analysis.

Results:

For each observer, the areas under the ROC curve were 0.953 and 0.969 for MRI, and 0.870 and 0.888 for MDCT (P < 0.05). The diagnostic accuracies (96.3% for each observer) and sensitivities (92.9% and 96.4%) of MRI in two observers were significantly higher than those (82.7% and 80.9%, 53.6% for each observer, respectively) of MDCT (P < 0.001). The negative predictive values (96.3% and 98.1%) of MRI in two observers were significantly higher than those (80.0% and 79.5%) of MDCT (P < 0.001). For each observer, specificities and positive predictive values did not differ significantly between the two techniques (P > 0.05).

Conclusion:

Gadoxetic acid‐enhanced MRI shows better diagnostic performance than that of MDCT for evaluating the viable tumors of HCCs treated with image‐guided tumor therapy. J. Magn. Reson. Imaging 2010;32:629–638. © 2010 Wiley‐Liss, Inc.     

3.0‐T MR‐guided focused ultrasound for preoperative localization of nonpalpable breast lesions: An initial experimental ex vivo study

Purpose

To compare the accuracy of magnetic resonance‐guided focused ultrasound (MRgFUS) with MR‐guided needle‐wire placement (MRgNW) for the preoperative localization of nonpalpable breast lesions.

Materials and Methods

In this experimental ex vivo study, 15 turkey breasts were used. In each breast phantom an artificial nonpalpable “tumor” was created by injecting an aqueous gel containing gadolinium. MRgFUS (n = 7) was performed with the ExAblate 2000 system (InSightec). With MRgFUS the ablated tissue changes in color and increases in stiffness. A rim of palpable and visible ablations was created around the tumor to localize the tumor and facilitate excision. MRgNW (n = 8) was performed by MR‐guided placement of an MR‐compatible needle‐wire centrally in the tumor. After surgical excision of the tumor, MR images were used to evaluate tumor‐free margins (negative/positive), minimum tumor‐free margin (mm), and excised tissue volume (cm³).

Results

With MRgFUS localization no positive margins were found after excision (0%). With MRgNW two excision specimens (25%) had positive margins (P = 0.48). Mean minimum tumor‐free margin (±SD) with MRgFUS was significantly larger (5.5 ± 2.4 mm) than with MRgNW (0.9 ± 1.4 mm) (P < 0.001). Mean volume ± SD of excised tissue did not differ between MRgFUS and MRgNW localization, ie, 44.0 ± 9.4 cm³ and 39.5 ± 10.7 cm³ (P = 0.3).

Conclusion

The results of this experimental ex vivo study indicate that MRgFUS can potentially be used to localize nonpalpable breast lesions in vivo. J. Magn. Reson. Imaging 2009;30:884–889. © 2009 Wiley‐Liss, Inc.     

Diffusion‐weighted echo‐planar magnetic resonance imaging for the assessment of tumor cellularity in patients with soft‐tissue sarcomas

Purpose

To investigate the eligibility of diffusion‐weighted imaging (DWI) for the evaluation of tumor cellularity in patients with soft‐tissue sarcomas.

Materials and Methods

Thirty consecutive patients with a total of 31 histologically‐proven soft‐tissue sarcomas prospectively underwent magnetic resonance imaging (MRI) including DWI with echo‐planar imaging (EPI) technique immediately before open biopsy (N = 1) or tumor resection (N = 30). Fourteen patients had no previous anticancer treatment, 16 had received neoadjuvant therapy. Tumor cellularity as determined from histological sections was compared with minimum apparent diffusion coefficient (ADC).

Results

Tumor cellularity correlated well with minimum ADC in a linear fashion, with a Pearson correlation coefficient of –0.88 (95% confidence interval [CI]: –0.75 to –0.96). This relationship was not influenced by prior anticancer treatment. There was only a tendency toward lower ADC in tumor with higher grading but no significant dependency (P = 0.08).

Conclusion

DWI has proven useful for the assessment of tumor cellularity in soft‐tissue sarcomas. In result, DWI may be used as a powerful noninvasive tool to monitor responses of cytotoxic treatment as reflected by changes in tumor cellularity. J. Magn. Reson. Imaging 2009. © 2009 Wiley‐Liss, Inc.     

MRI-guided vascular access with an active visualization needle

Purpose:

To develop an approach to vascular access under magnetic resonance imaging (MRI), as a component of comprehensive MRI‐guided cardiovascular catheterization and intervention.

Materials and Methods:

We attempted jugular vein access in healthy pigs as a model of “difficult” vascular access. Procedures were performed under real‐time MRI guidance using reduced field of view imaging. We developed an “active” MRI antenna‐needle having an open‐lumen, distinct tip appearance and indicators of depth and trajectory in order to enhance MRI visibility during the procedure. We compared performance of the active needle against an unmodified commercial passively visualized needle, measured by procedure success among operators with different levels of experience.

Results:

MRI‐guided central vein access was feasible using both the active needle and the unmodified passive needle. The active needle required less time (88 vs. 244 sec, P = 0.022) and fewer needle passes (4.5 vs. 9.1, P = 0.028), irrespective of operator experience.

Conclusion:

MRI‐guided access to central veins is feasible in our animal model. When image guidance is necessary for vascular access, performing this component under MRI will allow wholly MRI‐guided catheterization procedures that do not require adjunctive imaging facilities such as x‐ray or ultrasound. The active needle design showed enhanced visibility, as expected. These capabilities may permit more complex catheter‐based cardiovascular interventional procedures enabled by enhanced image guidance. J. Magn. Reson. Imaging 2011;. © 2011 Wiley Periodicals, Inc.     

Diffusion-weighted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients

Purpose:

To use dynamic contrast‐enhanced (DCE) and diffusion‐weighted (DW) MRI at 3 Tesla (T) for early evaluation of treatment effects in breast cancer patients undergoing neoadjuvant chemotherapy (NAC), and assess the reliability of DW‐MRI.

Materials and Methods:

DW‐ and DCE‐MRI acquisitions of 15 breast cancer patients were performed before and after one cycle of NAC. MRI tumor diameter and volume, apparent diffusion coefficient (ADC) and kinetic parameters (K^trans, v_e) were derived. The reliability of ADC before NAC was assessed. Changes in MRI parameters after NAC were analyzed, and logistic regression analysis was used to find the best predictors for pathologic response.

Results:

The reliability for ADC values was high, with intraclass correlation coefficient of 0.84 (P = 0.001). After one cycle of NAC, MRI tumor diameter (8%, P = 0.005) and tumor volume (30%, P = 0.008) was reduced for all patients, while ADC mean values increased (0.12 mm²/s, P = 0.008). The best predictor for treatment response was a change in MRI tumor diameter with mean error rate of 0.167 (13% for responders, 5% for nonresponders, P = 0.291).

Conclusion:

Changes in MRI derived tumor diameter and ADC after only one cycle of NAC could provide a valuable tool for early evaluation of treatment effects in breast cancer patients. J. Magn. Reson. Imaging 2011;. © 2011 Wiley Periodicals, Inc.     

PET/CT scanning guided intensity-modulated radiotherapy in treatment of recurrent ovarian cancer

Objective

This study was undertaken to evaluate the clinical contribution of positron emission tomography using ¹⁸F-fluorodeoxyglucose and integrated computer tomography (FDG-PET/CT) guided intensity-modulated radiotherapy (IMRT) for treatment of recurrent ovarian cancer.

Materials and methods

Fifty-eight patients with recurrent ovarian cancer from 2003 to 2008 were retrospectively studied. In these patients, 28 received PET/CT guided IMRT (PET/CT–IMRT group), and 30 received CT guided IMRT (CT–IMRT group). Treatment plans, tumor response, toxicities and survival were evaluated.

Results

Changes in GTV delineation were found in 10 (35.7%) patients based on PET–CT information compared with CT data, due to the incorporation of additional lymph node metastases and extension of the metastasis tumor. PET/CT guided IMRT improved tumor response compared to CT–IMRT group (CR: 64.3% vs. 46.7%, P = 0.021; PR: 25.0% vs. 13.3%, P = 0.036). The 3-year overall survival was significantly higher in the PET–CT/IMRT group than control (34.1% vs. 13.2%, P = 0.014).

Conclusions

PET/CT guided IMRT in recurrent ovarian cancer patients improved the delineation of GTV and reduce the likelihood of geographic misses and therefore improve the clinical outcome.     

Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging,and dynamic contrast‐enhanced MRI

Purpose

To develop a multi‐parametric model suitable for prospectively identifying prostate cancer in peripheral zone (PZ) using magnetic resonance imaging (MRI).

Materials and Methods

Twenty‐five radical prostatectomy patients (median age, 63 years; range, 44–72 years) had T2‐weighted, diffusion‐weighted imaging (DWI), T2‐mapping, and dynamic contrast‐enhanced (DCE) MRI at 1.5 Tesla (T) with endorectal coil to yield parameters apparent diffusion coefficient (ADC), T2, volume transfer constant (K^trans) and extravascular extracellular volume fraction (v_e). Whole‐mount histology was generated from surgical specimens and PZ tumors delineated. Thirty‐eight tumor outlines, one per tumor, and pathologically normal PZ regions were transferred to MR images. Receiver operating characteristic (ROC) curves were generated using all identified normal and tumor voxels. Step‐wise logistic‐regression modeling was performed, testing changes in deviance for significance. Areas under the ROC curves (A_z) were used to evaluate and compare performance.

Results

The best‐performing single‐parameter was ADC (mean A_z [95% confidence interval]: A_z,ADC: 0.689 [0.675, 0.702]; A_z,T2: 0.673 [0.659, 0.687]; A_z,Ktrans: 0.592 [0.578, 0.606]; A_z,ve: 0.543 [0.528, 0.557]). The optimal multi‐parametric model, LR‐3p, consisted of combining ADC, T2 and K^trans. Mean A_z,LR‐3p was 0.706 [0.692, 0.719], which was significantly higher than A_z,T2, A_z,Ktrans, and A_z,ve (P < 0.002). A_z,LR‐3p tended to be greater than A_z,ADC, however, this result was not statistically significant (P = 0.090).

Conclusion

Using logistic regression, an objective model capable of mapping PZ tumor with reasonable performance can be constructed. J. Magn. Reson. Imaging 2009;30:327–334. © 2009 Wiley‐Liss, Inc.     

Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion‐weighted MR imaging

Purpose:

To investigate the changes in apparent diffusion coefficients (ADCs) in cervical cancer patients receiving concurrent chemoradiotherapy (CCRT), and to assess the relationship between tumor ADCs or changes in tumor ADCs and final tumor responses to therapy.

Materials and Methods:

Twenty‐four patients with cervical cancer who received CCRT were examined with 3 Tesla (T) MRI including diffusion‐weighted imaging (DWI). All patients had three serial MR examinations: before therapy (pre‐Tx); at 4 weeks of therapy (mid‐Tx); and 1 month after completion of therapy (post‐Tx). At each examination, ADC was measured in tumors and normal gluteus muscles. Final tumor response as determined by change in tumor size or volume using MRI was correlated with tumor ADCs at each therapeutic time or changes in tumor ADCs at mid‐Tx.

Results:

From pre‐Tx to post‐Tx, mean tumor ADCs were 0.88, 1.30, and 1.47 × 10^?3 mm²/s in sequence (P < 0.001), while those of normal gluteus muscles were 1.24, 1.29, and 1.21 × 10^?3 mm²/s in sequence (P > 0.05). At mid‐Tx, tumor ADCs and changes in tumor ADCs had a significant correlation with final tumor size responses (P = 0.029 and 0.025, respectively). However, the tumor ADC values at pre‐Tx were not associated with the final tumor size response (P = 0.47). The final tumor volume response was not associated with tumor ADC at pre‐Tx or mid‐Tx (P > 0.05) or changes in tumor ADCs at mid‐Tx (P > 0.05).

Conclusion:

DWI may have potentials in evaluating the therapeutic response to CCRT in patients with cervical cancer. J. Magn. Reson. Imaging 2013;37:187–193. © 2012 Wiley Periodicals, Inc.

     

MRI-compatible manipulator with remote-center-of-motion control

Purpose

To develop and assess a needle‐guiding manipulator for MRI‐guided therapy that allows a physician to freely select the needle insertion path while maintaining remote center of motion (RCM) at the tumor site.

Materials and Methods

The manipulator consists of a three‐degrees‐of‐freedom (DOF) base stage and passive needle holder with unconstrained two‐DOF rotation. The synergistic control keeps the Virtual RCM at the preplanned target using encoder outputs from the needle holder as input to motorize the base stage.

Results

The manipulator assists in searching for an optimal needle insertion path which is a complex and time‐consuming task in MRI‐guided ablation therapy for liver tumors. The assessment study showed that accuracy of keeping the virtual RCM to predefined position is 3.0 mm. In a phantom test, the physicians found the needle insertion path faster with than without the manipulator (number of physicians = 3, P = 0.001). However, the alignment time with the virtual RCM was not shorter when imaging time for planning were considered.

Conclusion

The study indicated that the robot holds promise as a tool for accurately and interactively selecting the optimal needle insertion path in liver ablation therapy guided by open‐configuration MRI. J. Magn. Reson. Imaging 2008. © 2008 Wiley‐Liss, Inc.     

Diffusion‐weighted MRI for monitoring tumor response to photodynamic therapy

Purpose:

To examine diffusion‐weighted MRI (DW‐MRI) for assessing the early tumor response to photodynamic therapy (PDT).

Materials and Methods:

Subcutaneous tumor xenografts of human prostate cancer cells (CWR22) were initiated in athymic nude mice. A second‐generation photosensitizer, Pc 4, was delivered to each animal by a tail vein injection 48 h before laser illumination. A dedicated high‐field (9.4 Tesla) small animal MR scanner was used to acquire diffusion‐weighted MR images pre‐PDT and 24 h after the treatment. DW‐MRI and apparent diffusion coefficients (ADC) were analyzed for 24 treated and 5 control mice with photosensitizer only or laser light only. Tumor size, prostate specific antigen (PSA) level, and tumor histology were obtained at different time points to examine the treatment effect.

Results:

Treated mice showed significant tumor size shrinkage and decrease of PSA level within 7 days after the treatment. The average ADC of the 24 treated tumors increased 24 h after PDT (P < 0.001) comparing with pre‐PDT. The average ADC was 0.511 ± 0.119 × 10^?3 mm²/s pre‐PDT and 0.754 ± 0.181 × 10^?3 mm²/s 24 h after the PDT. There is no significant difference in ADC values pre‐PDT and 24 h after PDT in the control tumors (P = 0.20).

Conclusion:

The change of tumor ADC values measured by DW‐MRI may provide a noninvasive imaging marker for monitoring tumor response to Pc 4‐PDT as early as 24 h. J. Magn. Reson. Imaging 2010;32:409–417. © 2010 Wiley‐Liss, Inc.

     

Washout gradient in dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate cancer

Purpose:

To investigate the associations between dynamic contrast‐enhanced magnetic resonance imaging (DCE MRI) parameters and the Gleason score (GS) for prostate cancer (PCA) with localization information provided by concurrent apparent diffusion coefficient (ADC) maps.

Materials and Methods:

Forty‐three male patients received MR scans, including diffusion tensor imaging (DTI) and DCE MRI, on a 1.5 T MR system. All patients were confirmed to have PCA in the following biopsy within 2 weeks. ADC maps calculated from DTI were used to colocalize cancerous and noncancerous regions on DCE MRI for perfusion analysis retrospectively. Semiquantitative parameters (peak enhancement, initial gradient, and washout gradient [WG] and quantitative parameters [K^trans, ν_e, and k_ep]) were calculated and correlated with the GS. Receiver operating characteristic (ROC) analysis was used to evaluate the diagnostic performance of the perfusion parameters in assessing the aggressiveness of PCA.

Results:

A total of 41 PCA nodules were included in the analysis. Among all quantitative and semiquantitative parameters, only WG showed significant correlation with GS (r = ?0.75, P < 0.0001). By defining tumor aggressiveness as a GS >6, WG demonstrated a good diagnostic performance, with the area under the ROC curve being 0.88. Under a cutoff point of WG = 0.125 min^?1, the sensitivity and specificity were 0.87 and 0.78, respectively.

Conclusion:

WG shows a significant association with GS and good diagnostic performance in assessing tumor aggressiveness. Therefore, WG is a potential marker of GS. J. Magn. Reson. Imaging 2012;36:912–919. © 2012 Wiley Periodicals, Inc.

     

A new approach towards improved visualization of myocardial edema using T2-weighted imaging: a cardiovascular magnetic resonance (CMR) study

Purpose:

To compare T2‐weighted cardiovascular magnetic resonance (CMR) imaging with AASPIR (asymmetric adiabatic spectral inversion recovery) and STIR (short T1 inversion recovery) for myocardial signal intensity, image quality, and fat suppression.

Materials and Methods:

Forty consecutive patients (47 ± 16 years old) referred by cardiologists for CMR‐based myocardial tissue characterization were scanned with both STIR and AASPIR T2‐weighted imaging approaches. Signal intensity of left ventricular myocardium was normalized to a region of interest generating a signal‐to‐noise ratio (SNR). In six patients with regional edema on STIR the contrast‐to‐noise ratio (CNR) was assessed. Two independent observers used a scoring system to evaluate image quality and artifact suppression. Six healthy volunteers (three males, 32 ± 7 years) were recruited to compare fat suppression between AASPIR and STIR.

Results:

SNR of AASPIR was greater than STIR for basal (128 ± 44 vs. 83 ± 40, P < 0.001), mid‐ (144 ± 65 vs. 96 ± 39, P < 0.01), and apical (145 ± 59 vs. 105 ± 35, P < 0.05) myocardium. Improved image quality and greater suppression of artifacts was demonstrated with AASPIR. In patients with regional edema, CNR increased by 49% with AASPIR, while SNR of pericardial fat did not differ (44 ± 39 vs. 33 ± 30, P > 0.05).

Conclusion:

Our findings support the implementation of an AASPIR‐based approach for T2‐weighted imaging due to improved pericardial fat suppression, image quality, and artifact suppression with greater CNR and SNR. J. Magn. Reson. Imaging 2011;. © 2011 Wiley‐Liss, Inc.     

Perfusion parameters analysis of the vertebral bone marrow in patients with Ph¹⁻ chronic myeloproliferative neoplasms (Ph(neg) MPN): a dynamic contrast-enhanced MRI (DCE-MRI) study

Purpose:

To evaluate perfusion parameters of the vertebral bone marrow in patients with Philadelphia negative chronic myeloproliferative neoplasms (Ph^negMPN) using dynamic contrast‐enhanced MRI (DCE‐MRI).

Materials and Methods:

The study enrolled 24 patients with Ph^negMPN: 12 patients with myelofibrosis (Group A), 6 with essential thrombocythemia (ET), and 6 with polycythemia vera (PV) (Group B) who underwent DCE‐MRI of the lumbosacral spine. Twelve normal individuals served as control group (Group C). Wash‐in (WIN), wash‐out (WOUT), maximum contrast‐enhancement (CE), time‐to‐peak (TTPK), time‐to‐maximum slope (TMSP), and the WIN/TMSP ratio (WTSP) were calculated.

Results:

WIN, CE_max, and WTSP parameters were higher in Group A than in Group C (P < 0.05). These parameters were significant (P < 0.0001) in discriminating patients with myelofibrosis from normal individuals with sensitivities 74.14%, 87.93%, 74.14%, and specificities 91.07%, 83.93%, 91.07%, respectively. WIN, WOUT, CE_max, and WTSP parameters were higher in Group A than in Group B (P < 0.05). Group B exhibited no differences in perfusion parameters as compared with Group C with the exception of WOUT.

Conclusion:

Patients with myelofibrosis exhibited increased perfusion parameters in vertebral bone marrow, which could be consisted with increased vascularity, probably related to neoangiogenesis as opposed to ET or PV patients showing no increased perfusion. DCE‐MRI may be of value in discriminating subgroups of Ph^negMPN patients and in indicating those progressing to myelofibrosis. J. Magn. Reson. Imaging 2012;35:696‐702. © 2011 Wiley Periodicals, Inc.     

Value of Dual Energy Computed Tomography for detection of myocardial iron deposition in Thalassaemia patients: initial experience

Purpose

The aim of our study was to compare the value of cardiac DECT (cDECT) for detection of myocardial iron deposition to T2*w cardiac MRI (cMRI).

Material and methods

Nineteen patients with clinical history of Thalassaemia underwent T2*-weighted cardiac MRI (cMRI) with a 1.5 T MR scanner (MAGNETOM Symphony, Siemens Medical Solutions, Erlangen, Germany) and cardiac dual energy CT (cDECT) with a DSCT scanner (SOMATOM Definition, Siemens Medical Solutions, Erlangen, Germany) on the same day. HU values obtained from cDECT scans and T2*-values from cMRI were statistically correlated to calculate significance levels. Table times were measured for both cDECT and cMRI and compared. Patients were asked to grade their subjective comfort during the examination.

Results

In all patients cDECT scans were successfully acquired.HU values of septal muscle correlated strongly with T2*-values, whereas no correlation was found for paraspinal muscle.Table time was significantly shorter for cDECT compared to cMRI (mean: 3.7 min vs. 11.2 min) and subjective patient comfort was rated comfortable for cDECT and average to poor for cMRI. Mean radiation dose was 0.71 mSv.

Conclusion

cDECT scans seem to be possible for evaluation of myocardial iron load in pediatric Thalassaemia patients.     

Computer‐aided detection of brain tumor invasion using multiparametric MRI

Purpose

To determine the potential of using a computer‐aided detection method to intelligently distinguish peritumoral edema alone from peritumor edema consisting of tumor using a combination of high‐resolution morphological and physiological magnetic resonance imaging (MRI) techniques available on most clinical MRI scanners.

Materials and Methods

This retrospective study consisted of patients with two types of primary brain tumors: meningiomas (n = 7) and glioblastomas (n = 11). Meningiomas are typically benign and have a clear delineation of tumor and edema. Glioblastomas are known to invade outside the contrast‐enhancing area. Four classifiers of differing designs were trained using morphological, diffusion‐weighted, and perfusion‐weighted features derived from MRI to discriminate tumor and edema, tested on edematous regions surrounding tumors, and assessed for their ability to detect nonenhancing tumor invasion.

Results

The four classifiers provided similar measures of accuracy when applied to the training and testing data. Each classifier was able to identify areas of nonenhancing tumor invasion supported with adjunct images or follow‐up studies.

Conclusion

The combination of features derived from morphological and physiological imaging techniques contains the information necessary for computer‐aided detection of tumor invasion and allows for the identification of tumor invasion not previously visualized on morphological, diffusion‐weighted, and perfusion‐weighted images and maps. Further validation of this approach requires obtaining spatially coregistered tissue samples in a study with a larger sample size. J. Magn. Reson. Imaging 2009;30:481–489. © 2009 Wiley‐Liss, Inc.     

Late stimulation of the sphenopalatine‐ganglion in ischemic rats: Improvement in N‐acetyl‐aspartate levels and diffusion weighted imaging characteristics as seen by MR

Purpose:

To assess, by MR spectroscopy (MRS) and diffusion weighted imaging (DWI), the ability of electrical stimulation of the sphenopalatine ganglion (SPG) to augment stroke recovery in transient middle cerebral artery occluded (t‐MCAO) rats, when treatment is started 18 ± 2 h post‐occlusion.

Materials and Methods:

¹H‐MRS imaging (¹H‐MRSI) and DWI were used to evaluate ischemic brain tissue after SPG stimulation in rats subjected to 2 h of t‐MCAO. Rats were examined by ¹H‐MRSI, DWI, and behavioral tests at 16 ± 2 h, 8 days, and 28 days post‐MCAO.

Results:

N‐Acetyl‐aspartate (NAA) levels of the stimulated and control rats were the same 16 ± 2 h post‐MCAO (0.52 ± 0.03, 0.54 ± 0.03). At 28 days post‐occlusion, NAA levels were significantly higher in the treated group (0.60 ± 0.04) compared with those of the untreated animals (0.50 ± 0.04; P < 0.05). This effect was more pronounced for regions with low NAA values (0.16 ± 0.03) that changed to 0.32 ± 0.03 (P = 0.04) for the treated group and to 0.10 ± 0.03 (P = 0.20) for the controls. DWI data showed better ischemic tissue condition for the treated rats, but the measured parameters showed only a trend of improvement. The MR results were corroborated by behavioral examinations.

Conclusion:

Our findings suggest that SPG stimulation may ameliorate MR tissue characteristics following t‐MCAO even if treatment is started 18 h post‐occlusion. J. Magn. Reson. Imaging 2010;31:1355–1363. © 2010 Wiley‐Liss, Inc.     

Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE‐MRI

Purpose

To evaluate dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) as a tool for early prediction of response to neoadjuvant chemotherapy (NAC) and 5‐year survival in patients with locally advanced breast cancer.

Materials and Methods

DCE‐MRI was performed in patients scheduled for NAC (n = 24) before and after the first treatment cycle. Clinical response was evaluated after completed NAC. Relative signal intensity (RSI) and area under the curve (AUC) were calculated from the DCE‐curves and compared to clinical treatment response. Kohonen and probabilistic neural network (KNN and PNN) analysis were used to predict 5‐year survival.

Results

RSI and AUC were reduced after only one cycle of NAC in patients with clinical treatment response (P = 0.02 and P = 0.08). The mean and 10th percentile RSI values before NAC were significantly lower in patients surviving more than 5 years compared to nonsurvivors (P = 0.05 and 0.02). This relationship was confirmed using KNN, which demonstrated that patients who remained alive clustered in separate regions from those that died. Calibration of contrast enhancement curves by PNN for patient survival at 5 years yielded sensitivity and specificity for training and testing ranging from 80%–92%.

Conclusion

DCE‐MRI in locally advanced breast cancer has the potential to predict 5‐year survival in a small patient cohort. In addition, changes in tumor vascularization after one cycle of NAC can be assessed. J. Magn. Reson. Imaging 2009;29:1300–1307. © 2009 Wiley‐Liss, Inc.     

Contrast‐enhanced MRI of carotid atherosclerosis: Dependence on contrast agent

Purpose

To investigate the dependence of contrast‐enhanced magnetic resonance imaging (MRI) of carotid artery atherosclerotic plaque on the use of gadobenate dimeglumine versus gadodiamide.

Materials and Methods

Fifteen subjects with carotid atherosclerotic plaque were imaged with 0.1 mmol/kg of each agent. For arteries with interpretable images, the areas of the lumen, wall, and necrotic core and overlying fibrous cap (when present) were measured, as were the percent enhancement and contrast‐to‐noise ratio (CNR). A kinetic model was applied to dynamic imaging results to determine the fractional plasma volume, v_p, and contrast agent transfer constant, K^trans.

Results

For 12 subjects with interpretable images, the agent used did not significantly impact any area measurements or the presence or absence of necrotic core (P > 0.1 for all). However, the percent enhancement was greater for the fibrous cap (72% vs. 54%; P < 0.05) necrotic core (51% vs. 42%; P = 0.12), and lumen (42% vs. 63%; P < 0.05) when using gadobenate dimeglumine, although no apparent difference in CNR was found. Additionally, K^trans was lower when using gadobenate dimeglumine (0.0846 min^?1 vs. 0.101 min^?1; P < 0.01), although v_p showed no difference (9.5% vs. 10.1%; P = 0.39).

Conclusion

Plaque morphology measurements are similar with either contrast agent, but quantitative enhancement characteristics, such as percent enhancement and K^trans, differ. J. Magn. Reson. Imaging 2009;30:35–40. © 2009 Wiley‐Liss, Inc.

     

Value of oxygen-enhanced MRI of the lungs in patients with pulmonary hypertension: a qualitative and quantitative approach

Purpose:

To assess the clinical value of oxygen‐enhanced magnetic resonance imaging (oeMRI) in patients with pulmonary hypertension (PH) by correlation with ventilation/perfusion (V/Q) scintigraphy.

Materials and Methods:

In all, 33 patients with known PH underwent V/Q scintigraphy and oeMRI. oeMRI was used to assess the regional pulmonary function based on relative‐signal‐enhancement (RSE) and cross‐correlation‐coefficient (CCC) maps, evaluating mean RSE (mRSE), fraction of oxygen‐activated pixels (fOAP), and mean CCC (mCCC). Two reviewers, blinded to the results of scintigraphy, performed visual detection of diseased lung areas.

Results:

In 26 of the 33 patients (79%) the image quality of oeMRI reached a diagnostic level. In total, 150 lung areas were analyzed and compared. Sensitivities/specificities of oeMRI for detecting these defects were: RSE vs. ventilation scintigraphy 92%/73%; RSE vs. perfusion scintigraphy 60%/87%; CCC vs. ventilation scintigraphy 89%/81%; CCC vs. perfusion scintigraphy 50%/87%. The number of diseased lung areas in oeMRI correlated significantly with the number in V/Q scintigraphy (P < 0.01). mRSE showed a significant correlation with the number of diseased lung areas in ventilation scintigraphy (P < 0.05).

Conclusion:

oeMRI is feasible in PH patients, yielding an overall moderate agreement between oeMRI and V/Q scans, with a good sensitivity of oeMRI for the detection of ventilation defects as compared with ventilation scintigraphy. J. Magn. Reson. Imaging 2012;35:86‐94. © 2011 Wiley Periodicals, Inc.